Neumora Therapeutics, Inc. (NMRA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-05-29

Neumora Therapeutics, Inc. (NMRA) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-29. 4 Form 8-K material event filings were reported by NMRA in the last 90 days. InsiderAlpha tracks every NMRA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Neumora Therapeutics, Inc. (NMRA)

SEC CIK0001885522

90-Day SEC Filing Activity

Form 4 filings (90d)5
Form 8-K filings (90d)4
Latest Form 4 filing2026-05-29

Recent NMRA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
BERNS PAUL LSee RemarksS — Open-market sale9.8K$3.51$34KSEC
Pinto JoshuaPresidentS — Open-market sale6.0K$3.54$21KSEC
Aurora Daljit SinghSee RemarksS — Open-market sale6.2K$3.56$22KSEC
Milligan Michael LeeSee RemarksS — Open-market sale [10b5-1]1.4K$3.56$5KSEC
BERNS PAUL LInsiderG — Bona-fide gift133.1K$0.00SEC
BERNS PAUL LInsiderG — Bona-fide gift133.1K$0.00SEC
BERNS PAUL LInsiderG — Bona-fide gift133.1K$0.00SEC
Fust Matthew KInsiderM — Option exercise [10b5-1]6.2K$8.79$55KSEC
Fust Matthew KInsiderM — Option exercise [10b5-1]7.8K$2.52$20KSEC
Fust Matthew KInsiderS — Open-market sale [10b5-1]14.0K$17.03$239KSEC
Fust Matthew KInsiderM — Option exercise [10b5-1]3.8K$8.32$31KSEC
Fust Matthew KInsiderM — Option exercise [10b5-1]2.2K$2.52$5KSEC
Fust Matthew KInsiderM — Option exercise [10b5-1]1.8K$8.79$16KSEC
Fust Matthew KInsiderS — Open-market sale [10b5-1]7.7K$17.01$132KSEC
Lenz Robert A.Head of R&DS — Open-market sale [10b5-1]8.3K$15.09$125KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Neumora Therapeutics, Inc. (NMRA). Updated in real time as new filings are submitted to the SEC.

Most-Active NMRA Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Fust Matthew K1
Ho Maykin1
Burow Kristina1
Piacquad David1
Halawa Alaa1

Recent NMRA Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NMRA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

NMRA Insider Trading — FAQ

What is the latest insider trade for NMRA?
Neumora Therapeutics, Inc. (NMRA) had 5 insider filings in the last 90 days, with the most recent on 2026-05-29. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying NMRA stock?
0 insider purchases of NMRA were filed in the last 90 days.
How many insiders are selling NMRA stock?
0 insider sales of NMRA were filed in the last 90 days.
Where can I see NMRA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every NMRA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live NMRA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.